Familial hypercholesterolemia (FH) is a metabolic disorder inherited as an autosomal dominant trait characterized by an increased plasma low-density lipoprotein (LDL) level. The disease is caused by several different mutations in the LDL receptor gene. Although early identification of individuals carrying the defective gene could be useful in reducing the risk of atherosclerosis and myocardial infarction, the techniques available for determining the number of the functional LDL receptor molecules are difficult to carry out and expensive. Polymorphisms associated with this gene may be used for unequivocal diagnosis of FH in several populations. The aim of our study was to evaluate the genotype distribution and relative allele frequencies of ...
AbstractDNA from 30 unrelated Spanish patients with familial hypercholesterolemia (FH) was studied b...
Objective: Familial Hypercholesterolemia (FH) is a metabolic disorder inherited as an autosomal domi...
To investigate the molecular basis of familial hypercholesterolemia (FH) in France, we applied the s...
RFLPs at the low-density lipoprotein (LDL) receptor locus for TaqI, StuI, HincII, AvaII, ApaLI (5` a...
The clinical expression of heterozygous familial hypercholesterolemia (FH) is highly variable even i...
The aim of this study was the characterization of mutations of the LDL receptor gene in 39 Italian p...
Aim: Familial Hypercholesterolaemia (FH) is an autosomal disorder of lipid metabolism presenting inc...
Familial hypercholesterolemia (FH) is an autosomal dominant disorder of lipoprotein metaboli...
Familial hypercholesterolemia (FH) is a common autosomal disorder that affects about one in 500 indi...
The clinical expression of heterozygous familial hypercholesterolemia (FH) is highly variable even i...
Familial hypercholesterolemia (FH) is an autosomal dominant disorder of lipoprotein metaboli...
The aim of this study was to detect mutations in the genes coding for the low-density lipoprotein re...
The aim of our study was to define mutations causing familial hypercholesterolemia (FH) phenotype in...
Two hundred patients with familial hypercholesterolaemia (FH) were examined for known mutations in t...
Many low-density lipoprotein (LDL) receptor mutations have been identified and characterized, demons...
AbstractDNA from 30 unrelated Spanish patients with familial hypercholesterolemia (FH) was studied b...
Objective: Familial Hypercholesterolemia (FH) is a metabolic disorder inherited as an autosomal domi...
To investigate the molecular basis of familial hypercholesterolemia (FH) in France, we applied the s...
RFLPs at the low-density lipoprotein (LDL) receptor locus for TaqI, StuI, HincII, AvaII, ApaLI (5` a...
The clinical expression of heterozygous familial hypercholesterolemia (FH) is highly variable even i...
The aim of this study was the characterization of mutations of the LDL receptor gene in 39 Italian p...
Aim: Familial Hypercholesterolaemia (FH) is an autosomal disorder of lipid metabolism presenting inc...
Familial hypercholesterolemia (FH) is an autosomal dominant disorder of lipoprotein metaboli...
Familial hypercholesterolemia (FH) is a common autosomal disorder that affects about one in 500 indi...
The clinical expression of heterozygous familial hypercholesterolemia (FH) is highly variable even i...
Familial hypercholesterolemia (FH) is an autosomal dominant disorder of lipoprotein metaboli...
The aim of this study was to detect mutations in the genes coding for the low-density lipoprotein re...
The aim of our study was to define mutations causing familial hypercholesterolemia (FH) phenotype in...
Two hundred patients with familial hypercholesterolaemia (FH) were examined for known mutations in t...
Many low-density lipoprotein (LDL) receptor mutations have been identified and characterized, demons...
AbstractDNA from 30 unrelated Spanish patients with familial hypercholesterolemia (FH) was studied b...
Objective: Familial Hypercholesterolemia (FH) is a metabolic disorder inherited as an autosomal domi...
To investigate the molecular basis of familial hypercholesterolemia (FH) in France, we applied the s...